25 Stocks Moving In Thursday's Pre-Market Session

Gainers

• Aurinia Pharmaceuticals Inc AUPH rose 66.6 percent to $6.18 in pre-market trading after the company disclosed that Voclosporin met 48-week remission endpoints.
• Vermillion, Inc. VRML shares rose 20.9 percent to $2.84 in pre-market trading after the company reported a contracted in-network agreement with Blue Cross Blue Shield of Michigan for OVA1.
• Monster Beverage Corporation MNST rose 12.5 percent to $47.26 in pre-market trading after the company reported upbeat revenue for its fourth quarter.
• Charles Schwab Corp SCHW rose 9.8 percent to $47.20 in pre-market trading. Charles Schwab, Hong Kong, Ltd. disclosed that it will lower its standard online equity trade commissions.
• Ballard Power Systems Inc. (USA) BLDP shares rose 8.5 percent to $2.17 in pre-market trading as the company posted stronger-than-expected results for its fourth quarter.
• JD.Com Inc(ADR) JD rose 8.2 percent to $33.19 in pre-market trading. JD.com reported a Q4 loss of $0.18 per ADS on revenue of $11.558 billion. The company announced plans to sell 28.6 percent stake in JD Finance for RMB 14.3 billion in cash.
• EXACT Sciences Corporation EXAS rose 6.1 percent to $23.50 in pre-market trading. Exact Sciences and Mayo Clinic study showed a promise of new blood-based lung cancer test.
• Glaukos Corp GKOS shares rose 6 percent to $48.50 in pre-market trading after reporting strong Q4 results.
• Sarepta Therapeutics Inc SRPT rose 5.3 percent to $32.00 in pre-market trading. Leerink Swann upgraded Sarepta Therapeutics from Market Perform to Outperform, while Nomura initiated coverage on the stock with a Buy rating..
• Broadcom Ltd AVGO shares rose 5.3 percent to $226.50 in pre-market trading after the company reported stronger-than-expected results for its first quarter.
• Burlington Stores Inc BURL rose 3.2 percent to $91.50 in pre-market trading as the company reported upbeat results for its fourth quarter.

Find out what's going on in today's market and bring any questions you have to Benzinga's PreMarket Prep.

Losers

• Adeptus Health Inc ADPT fell 33.6 percent to $4.35 in pre-market trading after dropping 2.96 percent on Wednesday.
• Puma Biotechnology Inc PBYI shares fell 30.4 percent to $26.50 in the pre-market trading session. Puma Biotechnology reported Q4 adjusted loss of $1.22 per share. Puma Biotechnology also reported the publication of abstracts on neratinib for the AACR Annual Meeting 2017
• Stage Stores Inc SSI fell 28.9 percent to $1.65 in pre-market trading after the company reported weaker-than-expected earnings for its fourth quarter and issued a downbeat forecast for FY 2017.
• AXT Inc AXTI fell 12 percent to $6.60 in pre-market trading. AXT priced 4.6 million shares at $6.50 per share.
• Methode Electronics Inc. MEI fell around 9.8 percent to $39.10 in pre-market trading. Methode posted upbeat Q3 earnings, but lowered its sales forecast.
• Ares Management LP ARES fell 8.9 percent to $20.05 in pre-market trading. Ares Management reported the launch of 7.5 million unit secondary offering.
• Juno Therapeutics Inc JUNO dropped 6.8 percent to $23.60 in pre-market trading. Juno Therapeutics reported a Q4 loss of $0.51 per share on revenue of $21.153 million. Juno also announced plans to end development of its cancer drug.
• Ashford Hospitality Prime Inc AHP shares fell 6.5 percent to $12.06 in pre-market trading. Ashford Prime reported a 1.15 million share offering of common stock and announced plans to acquire Hotel Yountville for $96.5 million.
• Kratos Defense & Security Solutions, Inc KTOS fell 6.1 percent to $7.54 in pre-market trading after reporting a proposed public offering of common stock.
• Centrus Energy Corp LEU shares fell 5.7 percent to $5.60 in pre-market trading after declining 2.46 percent on Wednesday.
• HTG Molecular Diagnostics Inc HTGM shares fell 5.4 percent to $3.00 in pre-market trading after rising 16.12 percent on Wednesday.
• Opko Health Inc. OPK fell 4.7 percent to $7.98 in pre-market trading. OPKO Health reported a Q4 loss of $0.04 per share on revenue of $275.5 million.
• Kite Pharma Inc KITE fell 4.8 percent to $75.80 in pre-market trading. Kite reported commencement of 4.75 million share offering. Citigroup downgraded Kite Pharma from Buy to Neutral.
• Anheuser Busch Inbev NV (ADR) BUD fell 3.8 percent to $105.75 in pre-market trading on weak quarterly earnings. Bank of America downgraded Anheuser-Busch Inbev from Buy to Neutral.